But what are the real benefits, and who can truly benefit from this treatment
(The new advisory panel includes several members with ties to the peptides industry, raising concerns about its impartiality.) After the first day of deliberation, the panel voted in favor of easing restrictions on two popular peptidesBPC-157 and KPVdespite the fact that other FDA scientists have publicly raised concerns about the lack of evidence for these compounds
This finding has important safety implications, as elevated IGF-1 levels associated with full GH therapy raise concerns about increased cancer risk, particularly for individuals with pre-existing malignancies or strong family histories
Clin Exp Med (2019) 19(1):4753
Several important issues, however, remain to be addressed
Global thresholding was performed by an experienced operator